Table 2

Demographics, diagnostic testing, procedures and antibiotics given at discharge for pre and post groups

Preintervention (n=9)Postintervention (n=22)
Age, median (IQR), years9 (7–11)7.5 (3–10)
Gender, n (%)
 Male6 (67%)16 (73%)
Race, n (%)
 White8 (89%)17 (77%)
 Black1 (11%)4 (18%)
 Other0 (0%)1 (5%)
Site, n (%)
 Pelvis/thigh5 (56%)9 (41%)
 Lower leg4 (44%)2 (9%)
 Arm0 (0%)3 (14%)
 Hand0 (0%)3 (14%)
 Foot0 (0%)3 (14%)
 Clavicle0 (0%)2 (9%)
Organism
Staphylococcus aureus, oxacillin sensitive4 (44%)7 (32%)
S aureus, oxacillin resistant1 (11%)5 (23%)
Klebsiella oxytoca0 (0%)1 (5%)
Streptococcus pneumoniae0 (0%)1 (5%)
 None (Culture-negative)4 (44%)8 (36%)
Antibiotic class at discharge
 1st-generation cephalosporin4 (44%)3 (14%)
 3rd-generation cephalosporin0 (0%)1 (5%)
 Clindamycin5 (56%)16 (73%)
 Fluoroquinolone0 (0%)1 (5%)
 Combination clindamycin and fluoroquinolone0 (0%)1 (56%)
Procedure performed, n (%)
 Yes, arthrocentesis only2 (22%)6 (27%)
 Yes, incision and drainage0 (0%)8 (36%)